Authorization

DGAP-CMS: Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052


Fresenius Medical Care AG & Co. KGaA: Release of a capital market information


06.05.2019 / 12:09


Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.


- Share buy-back - 8th Interim Report
In the period from April 29, 2019 until and including May 03, 2019, a total
of 111,494 shares were repurchased within the framework of the share buyback
programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical
Care') announced on March 11, 2019 pursuant to Art. 5 para. 1 lit. a) of
Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU)
2016/1052.
The purchase was carried out exclusively by a credit institution
commissioned by Fresenius Medical Care via the XETRA trading platform on
the Frankfurt Stock Exchange:











Day of repurchase




Aggregated volume in




Weighted average share







number of shares




price










in EUR




29.04.2019




413




73.3889




30.04.2019




61,033




74.6422




02.05.2019




49,803




75.4376




03.05.2019




245




75.3642


The total volume of shares repurchased within the framework of this share
buy-back in the period from March 12, 2019 until and including May 03, 2019
therefore amounts to 3,673,262 shares.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Июнь 2020    »
ПнВтСрЧтПтСбВс
1234567
891011121314
15161718192021
22232425262728
2930